Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Mark Bresnik, MD
Executive Director, Clinical R&D
F2G, Ltd.
Disclosure(s): F2G Ltd: Employee
Poster(s):
(P-907)
Burden of Hospitalization for Coccidioidal Meningitis: A National Cohort Study
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
(P-911)
Antifungal Treatment Patterns, Healthcare Utilization, Costs and Mortality in Coccidioidal Meningitis Patients: A Descriptive Analysis of United States Nationwide Claims Database
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
(P-1010) Clinical and Economic Burden of Changing Initial Antifungal Regimens in Invasive Aspergillosis: A Hospital Perspective
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
(P-1011)
Real-World Antifungal Therapy Patterns in US Patients with Invasive Aspergillosis: It’s Complicated
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
